spot_img

about fansalaran

FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.

International News

Pharma Investment to establish manufacturing facility at SOHAR Freezone

SOHAR Port and Freezone has signed a land lease agreement with Pharma Investment Group, a joint venture between Omani investors and Algeria’s Spa IMGSA Group, to establish a pharmaceutical and medical supplies manufacturing facility within SOHAR Freezone. Spanning 40,000 sqm, this $20 million investment underscores SOHAR’s commitment to fostering a vibrant investment ecosystem that transforms trade in Oman through sustainable practices. With construction expected to commence in 2027, the new facility...

Editor

A Short Note by Dr. Amirhossein Hajimiri

A Short Note by Dr. Amirhossein Hajimiri With all my being, I have come to believe that the world can be set right—if I am open to criticism. If only for a moment, I doubt that what I say or do may not be entirely right; and if I accept the possibility that I, too, may be wrong. Or at the very least, I do not doubt that doubting is the path to salvation. This is the secret to moving toward modern thought—a process many societies have gradually undergone—where the individual...

BRANDING

Food and Drug

Novo Nordisk, Pfizer sweeten bid for Metsera as bidding war heats up

Novo Nordisk and Pfizer have revised their bids for...

Merck secures $700 million funding from Blackstone to develop cancer therapy

Merck said on Tuesday that it has entered into...

AstraZeneca wins shareholder backing for NYSE listing in US pivot

AstraZeneca shareholders approved a direct listing of the drugmaker's...

Interviews

AstraZeneca wins shareholder backing for NYSE listing in US pivot

AstraZeneca shareholders approved a direct listing of the drugmaker's...

BioNTech lifts 2025 revenue guidance on BMS partnership payment

Germany's BioNTech on Monday lifted its 2025 revenue guidance...

Industry News

Original Artical

Scientists change kidney blood type, a potential advance for transplant recipients

Researchers have converted a blood type A kidney to a blood type O kidney and successfully transplanted it, they reported in Nature Biomedical Engineering, an advance that could reduce wait times for new organs and save lives. Type O patients, who account for more than half of those on kidney waiting lists, can only receive organs from donors with type O blood, yet type O kidneys are often given to...

New Pill Lowers Stubborn Blood Pressure and May Slow Kidney Disease

A new drug lowered blood pressure and improved kidney health markers in high-risk patients. Phase 3 trials will test its long-term effects. Preliminary research suggests that adding the new medication baxdrostat to standard treatment may help lower blood pressure and slow the progression of kidney disease in individuals with chronic kidney disease who also have uncontrolled hypertension. The findings were presented at the American Heart Association’s Hypertension Scientific Sessions 2025. The...

Uncontrolled high blood pressure puts over a billion people at risk

The World Health Organization (WHO) today released its second Global hypertension report, showing that 1.4 billion people lived with hypertension in 2024, yet just over one in five have it under control either through medication or addressing modifiable health risks. The new report – released at an event co-hosted by WHO, Bloomberg Philanthropies, and Resolve to Save Lives during the 80th United Nations General Assembly – also reveals that only...

Follow us

Popular

spot_img

LEAVE A REPLY

Please enter your comment!
Please enter your name here